{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:45:35Z","timestamp":1769129135914,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This project was supported by grant from Basic Scientific Research Projects of Liaoning Provincial Education Department","award":["LJKZ0808"],"award-info":[{"award-number":["LJKZ0808"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12033-024-01104-x","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:01:39Z","timestamp":1710230499000},"page":"1054-1064","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sufentanil Suppresses Cell Carcinogenesis Via Targeting miR-186-5p\/HMGB1 Axis and Wnt\/\u03b2-Catenin Pathway in Non-Small-Cell Lung Cancer"],"prefix":"10.1007","volume":"67","author":[{"given":"Di","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-9922","authenticated-orcid":false,"given":"You","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal for Clinicians, 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"C Ca: A Cancer Journal for Clinicians"},{"key":"1104_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","volume":"13","author":"R Ruiz-Cordero","year":"2020","unstructured":"Ruiz-Cordero, R., & Devine, W. P. (2020). Targeted therapy and checkpoint immunotherapy in Lung Cancer. Surg Pathol Clin, 13, 17\u201333. https:\/\/doi.org\/10.1016\/j.path.2019.11.002.","journal-title":"Surg Pathol Clin"},{"key":"1104_CR3","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","volume":"28","author":"MB Schabath","year":"2019","unstructured":"Schabath, M. B., & Cote, M. L. (2019). Cancer Progress and priorities: Lung Cancer. Cancer Epidemiology, Biomarkers & Prevention, 28, 1563\u20131579. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0221.","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"1104_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma, N., Santana-Davila, R., & Molina, J. R. (2019). Non-small Cell Lung Cancer: Epidemiology, Screening, diagnosis, and treatment. Mayo Clinic Proceedings, 94, 1623\u20131640. https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.013.","journal-title":"Mayo Clinic Proceedings"},{"key":"1104_CR5","first-page":"35","volume":"44","author":"D Maciejewski","year":"2012","unstructured":"Maciejewski, D. (2012). Sufentanil in anaesthesiology and intensive therapy. Anaesthesiology Intensive Therapy, 44, 35\u201341.","journal-title":"Anaesthesiology Intensive Therapy"},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3340\/jkns.2016.0707.007","volume":"60","author":"DK Kim","year":"2017","unstructured":"Kim, D. K., Yoon, S. H., Kim, J. Y., Oh, C. H., Jung, J. K., & Kim, J. (2017). Comparison of the effects of Sufentanil and Fentanyl Intravenous patient controlled analgesia after lumbar Fusion. Journal of Korean Neurosurgical Society, 60, 54\u201359. https:\/\/doi.org\/10.3340\/jkns.2016.0707.007.","journal-title":"Journal of Korean Neurosurgical Society"},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4149\/BLL_2018_045","volume":"119","author":"Y Tire","year":"2018","unstructured":"Tire, Y., Sarkilar, G., Esen, H., Onoglu, R., & Uzun, S. T. (2018). The effect of intrathecal sufentanil preconditioning against myocardial ischemia-reperfusion injury. Bratislavske Lekarske Listy, 119, 240\u2013244. https:\/\/doi.org\/10.4149\/BLL_2018_045.","journal-title":"Bratislavske Lekarske Listy"},{"key":"1104_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/15384101.2021.1875668","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu, Q., Shang, Y., Bai, Y., Wu, Y., Wang, H., & Shen, T. (2021). Sufentanil preconditioning protects against myocardial ischemia\/reperfusion injury via miR-125a\/DRAM2 axis. Cell Cycle, 20, 383\u2013391. https:\/\/doi.org\/10.1080\/15384101.2021.1875668.","journal-title":"Cell Cycle"},{"key":"1104_CR9","doi-asserted-by":"publisher","first-page":"6267720","DOI":"10.1155\/2022\/6267720","volume":"2022","author":"L Qiu","year":"2022","unstructured":"Qiu, L., Zhong, G., Hou, Z., Lin, J., & Sun, L. (2022). Protective effect of Sufentanil on Myocardial Ischemia-Reperfusion Injury in rats by inhibiting endoplasmic reticulum stress. Computational and Mathematical Methods in Medicine, 2022, 6267720. https:\/\/doi.org\/10.1155\/2022\/6267720.","journal-title":"Computational and Mathematical Methods in Medicine"},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5114\/ceji.2014.45939","volume":"39","author":"W Wu","year":"2014","unstructured":"Wu, W., Wei, N., Jiang, C. N., Cui, S., & Yuan, J. (2014). Effects of sufentanil on human gastric cancer cell line SGC-7901 in vitro. Cent Eur J Immunol, 39, 299\u2013305. https:\/\/doi.org\/10.5114\/ceji.2014.45939.","journal-title":"Cent Eur J Immunol"},{"key":"1104_CR11","doi-asserted-by":"publisher","first-page":"7586100","DOI":"10.1155\/2021\/7586100","volume":"2021","author":"H Tang","year":"2021","unstructured":"Tang, H., Li, C., Wang, Y., & Deng, L. (2021). Sufentanil inhibits the proliferation and metastasis of Esophageal Cancer by inhibiting the NF-kappaB and snail signaling pathways. J Oncol, 2021, 7586100. https:\/\/doi.org\/10.1155\/2021\/7586100.","journal-title":"J Oncol"},{"key":"1104_CR12","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1080\/21655979.2022.2066045","volume":"13","author":"M Guan","year":"2022","unstructured":"Guan, M., Huang, Y., & Lin, X. (2022). Sufentanil inhibits the proliferation and epithelial mesenchymal transition of lung cancer cells through Wnt\/beta-catenin signaling pathway. Bioengineered, 13, 10857\u201310865. https:\/\/doi.org\/10.1080\/21655979.2022.2066045.","journal-title":"Bioengineered"},{"key":"1104_CR13","doi-asserted-by":"publisher","first-page":"e22080","DOI":"10.1016\/j.heliyon.2023.e22080","volume":"9","author":"MT Le","year":"2023","unstructured":"Le, M. T., Nguyen, H. T., Nguyen, X. H., Do, X. H., Mai, B. T., Ngoc Nguyen, H. T., Trang Than, U. T., & Nguyen, T. H. (2023). Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer. Heliyon, 9, e22080. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22080.","journal-title":"Heliyon"},{"key":"1104_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3349\/ymj.2019.60.9.842","volume":"60","author":"Y Shan","year":"2019","unstructured":"Shan, Y., & Li, P. (2019). Long intergenic non-protein coding RNA 665 regulates viability, apoptosis, and Autophagy via the MiR-186-5p\/MAP4K3 Axis in Hepatocellular Carcinoma. Yonsei Medical Journal, 60, 842\u2013853. https:\/\/doi.org\/10.3349\/ymj.2019.60.9.842.","journal-title":"Yonsei Medical Journal"},{"key":"1104_CR15","doi-asserted-by":"publisher","unstructured":"Chen, W., Li, Y., Zhong, J., & Wen, G. (2021). circ-PRKCI targets miR-1294 and mir-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. Molecular Medicine Reports, 23, https:\/\/doi.org\/10.3892\/mmr.2021.12103.","DOI":"10.3892\/mmr.2021.12103"},{"key":"1104_CR16","doi-asserted-by":"publisher","first-page":"e3394","DOI":"10.1002\/jgm.3394","volume":"24","author":"J Chu","year":"2022","unstructured":"Chu, J., Geng, G., Ai, X., Jia, W., Wang, J., Xu, B., Kong, X., & Kong, L. (2022). LINC01291 promotes hepatocellular carcinoma development by targeting the miR-186-5p\/OXSR1 axis. The Journal of Gene Medicine, 24, e3394. https:\/\/doi.org\/10.1002\/jgm.3394.","journal-title":"The Journal of Gene Medicine"},{"key":"1104_CR17","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.2147\/CMAR.S245941","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Jiang, Y., Xu, L., Qu, C., Zhang, L., Xiao, X., Chen, W., Li, K., Liang, Q., & Wu, H. (2020). circ-NRIP1 promotes glycolysis and tumor progression by regulating miR-186-5p\/MYH9 Axis in Gastric Cancer. Cancer Manag Res, 12, 5945\u20135956. https:\/\/doi.org\/10.2147\/CMAR.S245941.","journal-title":"Cancer Manag Res"},{"key":"1104_CR18","doi-asserted-by":"publisher","first-page":"663654","DOI":"10.3389\/fcell.2021.663654","volume":"9","author":"M Gao","year":"2021","unstructured":"Gao, M., Liu, L., Yang, Y., Li, M., Ma, Q., & Chang, Z. (2021). LncRNA HCP5 induces gastric Cancer Cell Proliferation, Invasion, and EMT processes through the miR-186-5p\/WNT5A Axis under Hypoxia. Front Cell Dev Biol, 9, 663654. https:\/\/doi.org\/10.3389\/fcell.2021.663654.","journal-title":"Front Cell Dev Biol"},{"key":"1104_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-021-10165-5","author":"X Shen","year":"2022","unstructured":"Shen, X., Zhu, X., Hu, P., Ji, T., Qin, Y., & Zhu, J. (2022). Knockdown circZNF131 inhibits cell progression and glycolysis in gastric Cancer through miR-186-5p\/PFKFB2 Axis. Biochemical Genetics. https:\/\/doi.org\/10.1007\/s10528-021-10165-5.","journal-title":"Biochemical Genetics"},{"key":"1104_CR20","doi-asserted-by":"publisher","first-page":"1166666","DOI":"10.3389\/fonc.2023.1166666","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang, Z., Zhou, X., Deng, X., Ye, D., Liu, D., Zhou, B., Zheng, W., Wang, X., Wang, Y., Borkhuu, O., & Fang, L. (2023). Mir-186-ANXA9 signaling inhibits tumorigenesis in breast cancer. Frontiers in Oncology, 13, 1166666. https:\/\/doi.org\/10.3389\/fonc.2023.1166666.","journal-title":"Frontiers in Oncology"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/jop.13288","volume":"51","author":"M Chen","year":"2022","unstructured":"Chen, M., & Zhang, J. (2022). Mir-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K\/AKT pathway. Journal of Oral Pathology and Medicine, 51, 322\u2013331. https:\/\/doi.org\/10.1111\/jop.13288.","journal-title":"Journal of Oral Pathology and Medicine"},{"key":"1104_CR22","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1159\/000475637","volume":"41","author":"H Wang","year":"2017","unstructured":"Wang, H., Shen, Q., Zhang, X., Yang, C., Cui, S., Sun, Y., Wang, L., Fan, X., & Xu, S. (2017). The long non-coding RNA XIST controls Non-small Cell Lung Cancer Proliferation and Invasion by modulating miR-186-5p. Cellular Physiology and Biochemistry, 41, 2221\u20132229. https:\/\/doi.org\/10.1159\/000475637.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"1104_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4149\/neo_2019_190511N420","volume":"67","author":"X Liu","year":"2020","unstructured":"Liu, X., Zhou, X., Chen, Y., Huang, Y., He, J., & Luo, H. (2020). Mir-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Neoplasma, 67, 147\u2013157. https:\/\/doi.org\/10.4149\/neo_2019_190511N420.","journal-title":"Neoplasma"},{"key":"1104_CR24","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.4153","author":"X Wang","year":"2021","unstructured":"Wang, X., Wang, H., Jiang, H., Qiao, L., & Guo, C. (2021). Circular RNAcirc_0076305 promotes cisplatin (DDP) resistance of Non-small Cell Lung Cancer cells by regulating ABCC1 through miR-186-5p. Cancer Biotherapy & Radiopharmaceuticals. https:\/\/doi.org\/10.1089\/cbr.2020.4153.","journal-title":"Cancer Biotherapy & Radiopharmaceuticals"},{"key":"1104_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-020-00950-x","volume":"13","author":"S Wang","year":"2020","unstructured":"Wang, S., & Zhang, Y. (2020). HMGB1 in inflammation and cancer. Journal of Hematology & Oncology, 13, 116. https:\/\/doi.org\/10.1186\/s13045-020-00950-x.","journal-title":"Journal of Hematology & Oncology"},{"key":"1104_CR26","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1002\/jcp.30125","volume":"236","author":"J Xue","year":"2021","unstructured":"Xue, J., Suarez, J. S., Minaai, M., Li, S., Gaudino, G., Pass, H. I., Carbone, M., & Yang, H. (2021). HMGB1 as a therapeutic target in disease. Journal of Cellular Physiology, 236, 3406\u20133419. https:\/\/doi.org\/10.1002\/jcp.30125.","journal-title":"Journal of Cellular Physiology"},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1002\/jcb.28157","volume":"120","author":"H Ai","year":"2019","unstructured":"Ai, H., Zhou, W., Wang, Z., Qiong, G., Chen, Z., & Deng, S. (2019). microRNAs-107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1. Journal of Cellular Biochemistry, 120, 8696\u20138705. https:\/\/doi.org\/10.1002\/jcb.28157.","journal-title":"Journal of Cellular Biochemistry"},{"key":"1104_CR28","doi-asserted-by":"publisher","first-page":"111200","DOI":"10.1016\/j.intimp.2023.111200","volume":"126","author":"M Jiang","year":"2023","unstructured":"Jiang, M., Liu, L., Huang, W., Qi, Y., Li, Y., & Li, B. (2023). HMGB1-activated tumor-associated macrophages promote migration and invasion via NF-\u03baB\/IL-6 signaling in oral squamous cell carcinoma. International Immunopharmacology, 126, 111200. https:\/\/doi.org\/10.1016\/j.intimp.2023.111200.","journal-title":"International Immunopharmacology"},{"key":"1104_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12935-020-01278-9","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Guo, R., Qiao, Y., Han, L., & Liu, M. (2020). LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1\/miR-186\/HMGB1 axis. Cancer Cell International, 20, 190. https:\/\/doi.org\/10.1186\/s12935-020-01278-9.","journal-title":"Cancer Cell International"},{"key":"1104_CR30","doi-asserted-by":"publisher","first-page":"153303382094805","DOI":"10.1177\/1533033820948054","volume":"19","author":"XH Wang","year":"2020","unstructured":"Wang, X. H., Zhang, S. Y., Shi, M., & Xu, X. P. (2020). HMGB1 promotes the proliferation and metastasis of Lung Cancer by activating the Wnt\/beta-Catenin pathway. Technology in Cancer Research & Treatment, 19, 1533033820948054. https:\/\/doi.org\/10.1177\/1533033820948054.","journal-title":"Technology in Cancer Research & Treatment"},{"key":"1104_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10616-017-0127-y","volume":"70","author":"H Tao","year":"2018","unstructured":"Tao, H., Nuo, M., & Min, S. (2018). Sufentanil protects the rat myocardium against ischemia-reperfusion injury via activation of the ERK1\/2 pathway. Cytotechnology, 70, 169\u2013176. https:\/\/doi.org\/10.1007\/s10616-017-0127-y.","journal-title":"Cytotechnology"},{"key":"1104_CR32","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.12659\/MSM.913145","volume":"25","author":"YH Lian","year":"2019","unstructured":"Lian, Y. H., Fang, J., Zhou, H. D., Jiang, H. F., & Xie, K. J. (2019). Sufentanil Preconditioning protects against hepatic ischemia-reperfusion Injury by suppressing inflammation. Medical Science Monitor, 25, 2265\u20132273. https:\/\/doi.org\/10.12659\/MSM.913145.","journal-title":"Medical Science Monitor"},{"key":"1104_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10753-020-01410-x","volume":"44","author":"L Zhou","year":"2021","unstructured":"Zhou, L., Yang, X., Shu, S., Wang, S., Guo, F., Yin, Y., Zhou, W., Han, H., & Chai, X. (2021). Sufentanil protects the liver from Ischemia\/Reperfusion-Induced inflammation and apoptosis by inhibiting ATF4-Induced TP53BP2 expression. Inflammation, 44, 1160\u20131174. https:\/\/doi.org\/10.1007\/s10753-020-01410-x.","journal-title":"Inflammation"},{"key":"1104_CR34","doi-asserted-by":"publisher","unstructured":"Wang, Z., Du, X., Yu, D., Yang, Y., Ma, G., Jia, X., & Cheng, L. (2022). Sufentanil alleviates cerebral ischemia-reperfusion injury by inhibiting inflammation and protecting the blood-brain barrier in rats. European Journal of Histochemistry, 66, https:\/\/doi.org\/10.4081\/ejh.2022.3328.","DOI":"10.4081\/ejh.2022.3328"},{"key":"1104_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10585-023-10199-6","volume":"40","author":"S Xu","year":"2023","unstructured":"Xu, S., Li, X., Li, W., Ma, N., Ma, H., Cui, J., You, X., & Chen, X. (2023). Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition. Clinical & Experimental Metastasis, 40, 149\u2013160. https:\/\/doi.org\/10.1007\/s10585-023-10199-6.","journal-title":"Clinical & Experimental Metastasis"},{"key":"1104_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1089\/acm.2014.0310","volume":"21","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Tang, H., Guo, Q., Liu, J., Liu, X., Luo, J., & Yang, W. (2015). Effects of Intravenous patient-controlled Sufentanil Analgesia and Music Therapy on Pain and Hemodynamics after surgery for Lung Cancer: A randomized parallel study. Journal of Alternative and Complementary Medicine, 21, 667\u2013672. https:\/\/doi.org\/10.1089\/acm.2014.0310.","journal-title":"Journal of Alternative and Complementary Medicine"},{"issue":"Suppl 1","key":"1104_CR37","doi-asserted-by":"publisher","first-page":"C128","DOI":"10.4103\/0973-1482.163870","volume":"11","author":"Y Zhou","year":"2015","unstructured":"Zhou, Y., Huang, J. X., Lu, X. H., Zhang, Y. F., & Zhang, W. (2015). Patient-controlled intravenous analgesia for non-small cell lung cancer patient after thoracotomy. Journal of Cancer Research and Therapeutics, 11(Suppl 1), C128\u2013C130. https:\/\/doi.org\/10.4103\/0973-1482.163870.","journal-title":"Journal of Cancer Research and Therapeutics"},{"key":"1104_CR38","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1053\/j.jvca.2017.11.015","volume":"32","author":"M Rispoli","year":"2018","unstructured":"Rispoli, M., Fiorelli, A., Nespoli, M. R., Esposito, M., Corcione, A., & Buono, S. (2018). Sufentanil Sublingual Tablet System for theManagement of Postoperative Pain Aftervideo-assisted thoracic surgery: APreliminary Clinical Experience. Journal of Cardiothoracic and Vascular Anesthesia, 32, e61\u2013e63. https:\/\/doi.org\/10.1053\/j.jvca.2017.11.015.","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"key":"1104_CR39","doi-asserted-by":"publisher","unstructured":"Lee, S. S., & Cheah, Y. K. (2019). The interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on non-small-cell Lung Cancer (NSCLC) Progression. J Immunol Res, 2019(3046379). https:\/\/doi.org\/10.1155\/2019\/3046379.","DOI":"10.1155\/2019\/3046379"},{"key":"1104_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.trsl.2020.11.012","volume":"230","author":"S Zhong","year":"2021","unstructured":"Zhong, S., Golpon, H., Zardo, P., & Borlak, J. (2021). miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Translational Research : The Journal of Laboratory and Clinical Medicine, 230, 164\u2013196. https:\/\/doi.org\/10.1016\/j.trsl.2020.11.012.","journal-title":"Translational Research : The Journal of Laboratory and Clinical Medicine"},{"key":"1104_CR41","doi-asserted-by":"publisher","first-page":"11456","DOI":"10.1080\/21655979.2022.2066753","volume":"13","author":"Y Yue","year":"2022","unstructured":"Yue, Y., Xu, F., Zhang, J., Zhao, M., & Zhou, F. (2022). Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11beta-Hydroxysteroid dehydrogenase type 2. Bioengineered, 13, 11456\u201311470. https:\/\/doi.org\/10.1080\/21655979.2022.2066753.","journal-title":"Bioengineered"},{"key":"1104_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13018-022-03059-8","volume":"17","author":"F Lin","year":"2022","unstructured":"Lin, F., Wang, X., Zhao, X., Ren, M., Wang, Q., & Wang, J. (2022). Circ_0001174 facilitates osteosarcoma cell proliferation, migration, and invasion by targeting the miR-186-5p\/MACC1 axis. J Orthop Surg Res, 17, 159. https:\/\/doi.org\/10.1186\/s13018-022-03059-8.","journal-title":"J Orthop Surg Res"},{"key":"1104_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen, R., Kang, R., & Tang, D. (2022). The mechanism of HMGB1 secretion and release. Experimental & Molecular Medicine, 54, 91\u2013102. https:\/\/doi.org\/10.1038\/s12276-022-00736-w.","journal-title":"Experimental & Molecular Medicine"},{"key":"1104_CR44","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.3892\/ol.2018.8215","volume":"15","author":"L Wu","year":"2018","unstructured":"Wu, L., & Yang, L. (2018). The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications. Oncol Lett, 15, 6799\u20136805. https:\/\/doi.org\/10.3892\/ol.2018.8215.","journal-title":"Oncol Lett"},{"key":"1104_CR45","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.26355\/eurrev_202002_20390","volume":"24","author":"H Zhou","year":"2020","unstructured":"Zhou, H., Zhu, Z. H., Liu, Y., & Liu, Y. Y. (2020). Effects of midazolam combined with sufentanil on injury and expression of HMGB1 and NF-kappaB in rats with pancreatitis. European Review for Medical and Pharmacological Sciences, 24, 2102\u20132109. https:\/\/doi.org\/10.26355\/eurrev_202002_20390.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"1104_CR46","doi-asserted-by":"publisher","first-page":"300060520986351","DOI":"10.1177\/0300060520986351","volume":"49","author":"Q Gao","year":"2021","unstructured":"Gao, Q., Chang, N., & Liu, D. (2021). In vitro and in vivo assessment of the protective effect of sufentanil in acute lung injury. Journal of International Medical Research, 49, 300060520986351. https:\/\/doi.org\/10.1177\/0300060520986351.","journal-title":"Journal of International Medical Research"},{"key":"1104_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy, N., & Kurzrock, R. (2018). Targeting the Wnt\/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treatment Reviews, 62, 50\u201360. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.002.","journal-title":"Cancer Treatment Reviews"},{"key":"1104_CR48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/08923973.2023.2228476","volume":"45","author":"M Li","year":"2023","unstructured":"Li, M., Gu, K., Kong, Q., Wang, G., & Gu, J. (2023). Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-\u03baB pathway. Immunopharmacology and Immunotoxicology, 45, 663\u2013671. https:\/\/doi.org\/10.1080\/08923973.2023.2228476.","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"1104_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3892\/etm.2022.11364","volume":"24","author":"L Wang","year":"2022","unstructured":"Wang, L., Ge, C., & Zhang, X. (2022). Sufentanil ameliorates oxygen-glucose deprivation\/reoxygenation-induced endothelial barrier dysfunction in HCMECs via the PI3K\/Akt signaling pathway. Exp Ther Med, 24, 437. https:\/\/doi.org\/10.3892\/etm.2022.11364.","journal-title":"Exp Ther Med"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01104-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01104-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01104-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:13:56Z","timestamp":1738930436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01104-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01104-x","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Jinzhou Medical University and with the written consent of all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}